Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · IEX Real-Time Price · USD
7.42
-0.15 (-1.98%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Voyager Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for VYGR stock have an average target of 18.57, with a low estimate of 14 and a high estimate of 30. The average target predicts an increase of 150.27% from the current stock price of 7.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2024.
Analyst Ratings
The average analyst rating for VYGR stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 5 | 5 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +196.50% | Mar 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +304.31% | Mar 19, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +115.63% | Mar 7, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $9 → $14 | Hold → Buy | Upgrades | $9 → $14 | +88.68% | Jan 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $16 | Buy | Reiterates | $16 | +115.63% | Aug 7, 2023 |
Financial Forecast
Revenue This Year
39.62M
from 250.01M
Decreased by -84.15%
Revenue Next Year
55.18M
from 39.62M
Increased by 39.28%
EPS This Year
-1.83
from 2.97
EPS Next Year
-1.76
from -1.83
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 94.6M | 162.7M | 129.0M | 94.5M | 105.0M |
| Avg | 39.6M | 55.2M | 56.6M | 37.4M | 40.8M |
| Low | 4.9M | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -62.1% | 310.6% | 133.7% | 67.1% | 180.7% |
| Avg | -84.2% | 39.3% | 2.5% | -33.9% | 9.1% |
| Low | -98.0% | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.64 | 0.16 | -0.65 | -1.31 | -1.20 |
| Avg | -1.83 | -1.76 | -1.48 | -1.28 | -1.16 |
| Low | -2.84 | -4.10 | -2.25 | -1.23 | -1.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.